English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Gilead Sciences Inc. Healthcare Policy PAC

Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'

Trending

+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'

+ Pharmaceuticals
Patient Daily | Jul 21, 2025

Executive director of COA on 340B abuse: ‘Imagine using cancer patients as a source of revenue’

Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas

Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily